CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 3, 2012, Pages 339-340

  Uzawa, Akiyuki ^a   Mori, Masahiro ^a   Sato, Yasunori ^b   Masuda, Saeko ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; BETA INTERFERON; INTERLEUKIN 6; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; CLINICAL ARTICLE; DRUG MEGADOSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LETTER; MYELOOPTIC NEUROPATHY; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; REMISSION;

EID: 84857053592     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2011.241760     Document Type: Letter

References (5)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-15. (Pubitemid 47238676)
2. Uzawa A, Mori M, Arai K, et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler 2010;16:1443-52.
3. Ishizu T, Osoegawa M, Mei FJ, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005;128:988-1002. (Pubitemid 40675455)
4. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218-22.
5. Kaplin AI, Deshpande DM, Scott E, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005;115:2731-41. (Pubitemid 41434400)